Dr. Krishna Bhavanasi

Dr. Krishna Bhavanasi currently serves as the Vice President of Formulation Development at Torrent Pharmaceuticals Ltd, a position held since September 2024. Prior to this role, Dr. Bhavanasi was the Chief Scientific Officer at EXTROVIS from January 2024 to August 2024, and Vice President at NATCO Pharma from April 2022 to January 2024. Dr. Bhavanasi's extensive experience includes various leadership roles at Natco Pharma Ltd from June 2013 to March 2022, as well as a Senior Scientist position in Formulation Development at Aurobindo Pharma Ltd from December 2005 to May 2013. Dr. Bhavanasi's academic background includes a PhD in Pharmaceutics from Universiti Sains Malaysia, alongside a certificate in Strategic and Leadership from the Indian Institute of Management, Indore, and an M.Pharmacy in Pharmacy from Andhra University.